NCT00674752
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- Pfizer Investigational Site Miami, Florida, United States
- Pfizer Investigational Site Atlanta, Georgia, United States
- Pfizer Investigational Site Overland Park, Kansas, United States
- Pfizer Investigational Site Cincinnati, Ohio, United States